Brits still have a poor perception of asthma

Considering there are a staggering 5.4 million asthmatics in Britain, it could be assumed that the majority of us are pretty clued-up on the serious lung condition asthma. Unfortunately, the results of a new survey suggest this could be far from the truth.

Research conducted by supermarket giant Asda showed that whilst 94% acknowledge asthma as a serious health condition, 1 in four respondents could not recognise key symptoms associated with asthma. In fact, 17% incorrectly believed blocked sinuses are a sign of the lung condition.

An additional 15% of those surveyed simply thought feeling dizzy was asthma-related and 13% bizarrely assumed having itchy eyes was somehow a key symptom of asthma. In reality, the primary common symptoms of asthma are having a shortness of breath, wheezing (accompanied by a whistling sound), chest tightness/pain/pressure, coughing (especially at night or early in the morning).
Sufferers usually find their symptoms to be particularly worse at night time, after exposure to cold air, exercise-induced, or brought-on by a reaction to an allergen – similar to hay fever sufferers.

Other wrong assumptions held by Brits include thinking there is a permanent cure for the lifelong condition; incredibly a third of us believe this to be true. Moreover, 15% merely think that asthma is something that only ‘unfit’ people have.

This is clearly untrue though and many are obviously forgetting the countless famous asthma sufferers who have reached the top of their field, such as the multimillionaire and recently retired footballer David Beckham and cyclist Laura Trott, who won gold at the London 2012 Summer Olympic Games in the Team Pursuit and Omnium events.

However, asthma attacks still cause around 1,140 deaths each year and a substantial number of those could have been avoided with more awareness about the condition and how to efficiently control it. Only 37% of Brits have a decent knowledge about asthma medication or can differentiate between the purpose of blue and brown inhalers.

Unfortunately, this perhaps demonstrate a worrying lack of awareness about the fact a person’s asthma can be better controlled with regular and correct utilisation of brown preventer inhalers such as the commonly used Qvar Beclometasone and Easi-Breathe inhalers. Over time, the brown preventers are effective at reducing the need for blue inhalers – which are taken immediately to relieve asthma symptoms and essential in treating asthma attacks.

Visit the ‘Asthma and Allergies’ area of the Medical Specialists Pharmacy website for a full list of all the preventer and reliever inhalers we provide for suitable patients.

If you have already been prescribed an inhaler, have lost your inhaler, or run out and cannot get a prescription immediately, we are able to supply you an inhaler to help your asthma symptoms. You can undergo a quick and easy confidential online consultation with one of our GMC-registered Doctors and if suitable, they will write you a prescription which is passed to our in-house RPSGB–registered Pharmacists and dispensed to a location of your choice, all within just 24 hours!*

*Allow extra time for overseas deliveries.

Fungi found in the lungs could offer clues about asthma

Welsh scientists could have made an important breakthrough in the development of affective asthma treatment after discovering hundreds of varying fungal particles within the lungs of both asthma sufferers, and healthy individuals who did not have the lung condition.

Previously, many would have assumed that our lungs were absent of life, so the new discovery that the lungs are host to organisms may now prove massively beneficial for the 5.4 million people across the UK who have asthma.

The large study, which is the first of its kind, has been published in the journal BMC Infectious Disease. It shows how the team from Cardiff University’s School of Medicine have managed to detect high numbers of fungi existing in healthy lungs, whilst also finding other differing kinds of fungi in asthma patients.

“Historically, the lungs were thought to be sterile”, says Hugo van Woerden from Cardiff University’s Institute of Primary Care and Public Health, who led the research.

He continued: “Our analysis found that there are large numbers of fungi present in healthy human lungs. The study also demonstrates that asthma patients have a large number of fungi in their lungs and that the species of fungi are quite different to those present in the lungs of healthy individuals.”

Van Woerden and his colleagues analysed the mucus or sputum from a large collection of patients both with and without asthma and subsequently unearthed some 136 different fungal species from the induced sputum samples. Of this total, 90 fungal species more prevalent within the lungs of asthma patients and 46 were more common within the lungs of patients who did not suffer from asthma.

“Establishing the presence of fungi in the lungs of patients with asthma could potentially open up a new field of research which brings together molecular techniques for detecting fungi and developing treatments for asthma. In the future it is conceivable that individual patients may have their sputum tested for fungi and their treatment adjusted accordingly”, added van Woerden.

Cardiff researchers have previously established a link between fungi and asthma however and they have said in the past that by eradicating fungi from people’s homes, this could dramatically help life for those who suffer with asthma.

Medical Specialists Pharmacy is able to help you if you are suffering from asthma. We can provide any new or existing asthma patient with a wide range of medications. If you have already been prescribed an inhaler, have lost your inhaler, or run out and cannot get a prescription immediately, we are able to supply you an inhaler to help your asthma symptoms. You can undergo a quick and easy confidential online consultation with one of our GMC-registered Doctors and if suitable, they will write you a prescription which is passed to our in-house RPSGB–registered Pharmacists and dispensed to a location of your choice. We have both blue (relievers) inhalers such as Ventolin and Salbutamol, and brown (preventers) inhalers such as Qvar Beclomethasone and Qvar Easi-Breathe.

Pregnant women taking antibiotics leave babies at risk of asthma

A new Danish study has emerged that shows potential dangers to children if their mothers take antibiotics during pregnancy, with these children possibly more likely to develop asthma in comparison to children whose mothers did not take any antibiotics when expecting.

The researchers state that results they have gathered from their study are not 100% definitive in proving that antibiotics were completely responsible for the apparent increased asthma risk. However their data does back-up an already known theory that the body’s own ‘friendly’ bacteria play an important role in whether or not a child develops asthma, with antibiotics seemingly sabotaging these good bacteria.

Dr. Hans Bisgaard, a professor at the University of Copenhagen, was one of a few authors of the study, published in The Journal of Pediatrics. He said: “We speculate that mothers’ use of antibiotics changes the balance of natural bacteria, which is transmitted to the new-born, and that such unbalanced bacteria in early life impact on the immune maturation in the new-born.”

Anita Kozyrskyj, a professor at the University of Alberta, has also conducted her own studies trying to ascertain asthma and antibiotic links, and she believes it is these effects on the immune system could end up leading to a development of asthma later on, although she is still trying to work out exactly how.

Although there have been arguments against the findings, previous research has suggested that those children who are given antibiotics during the first six months of their life are at a 52% more risk of developing asthma and allergies by the time they are 6 years old.

Dr Bisgaard and his colleagues however decided to focus their research on the effects of antibiotics earlier than infancy. To do this they obtained information from a Danish national birth database comprising of over 30,000 children who were born sometime between 1997 and 2003. The team’s follow-up analysis spanned for a total of five years.

It was discovered that approximately a quarter of the children (7,300), had mothers who had taken antibiotics during their pregnancy. Of these children, just over 3% had been admitted to hospital for their asthma prior to the age of five.

In total, it was found that 581 (2.5%) of the approximate 23,000 children not exposed to antibiotics, had been admitted to hospital for asthma.

Dr Bisgaard and his team then looked at other possible risk factors for asthma and managed to calculate that the children that had been exposed to antibiotics whilst in the womb were around 17% more likely to require hospital treatment for asthma conditions.

Also it was calculated that those children with mothers who had taken antibiotics during pregnancy were 18% more likely to have been issued a prescription for asthma medicine such as Ventolin for example, compared to kids whose mothers did not take antibiotics when they were pregnant.

If you are suffering from asthma, why not allow At Medical Specialists Pharmacy to help you as we are able to provide new and existing asthma patients with a wide range of medications. If you have already been prescribed an inhaler, have lost your inhaler, or run out and cannot get a prescription immediately, we are able to supply you an inhaler to help your asthma symptoms. After undergoing a private and confidential online consultation with one of our Doctors, if you are suitable they will then write you a prescription which is passed to our in-house Pharmacists and dispensed to a location of your choice. We have both blue (relievers) inhalers such as Ventolin and Salbutamol, and brown (preventers) inhalers such as Qvar Beclomethasone and Qvar Easi-Breathe.

New drug Tudorza Pressair is given FDA backing for the treatment of COPD

This week has seen yet another new drug been given a clearance by The Food and Drug Administration (FDA), following the recent seal of approval for two new weight loss medications, Qsymia and Belviq, as we reported last week.

On this occasion, the drug to be given an authorisation for public use is a twice-daily inhaled medication named ‘Tudorza Pressair’, which is used to help treat symptoms of bronchospasm. This is associated with chronic obstructive pulmonary disease (COPD), aka ‘smoker’s cough’.

COPD is a term used for numerous conditions, including chronic bronchitis and emphysema, and is similar in certain characteristics to asthma. Bronchitis and emphysema are commonly co-existing diseases of the lungs in which the airways become narrowed, thus making it difficult for air to get in or out of the lungs.  Obvious symptoms can include chronic cough, tightness in the chest, and excessive phlegm.

Asthma and COPD can exist in the same person. However, in contrast to asthma, the inflammation of the lungs with COPD is not triggered by allergies and does not respond well to anti-inflammatory medication. In 2005, there were over 3 million deaths worldwide linked to COPD, with the main cause being the damaging effects of cigarette smoking.

On Tuesday, Spain’s biggest pharmaceutical company Almirall, and US drugmaker Forest Laboratories, confirmed they had been given the coveted FDA green light for Tudorza Pressair. This followed a slight hiccup back in March when the FDA demanded that it wanted a three-month extended time period to analyse the review data supporting the New Drug Application for aclidinium bromide (the powder ingredient within Tudorza Pressair).

Despite entering into an already competitive market where highly popular effective medications such as Ventolin can alleviate COPD symptoms, analysts at Sanford Bernstein say that sales of the Forest/Almirall drug could hit $164 million by 2015.

A spokesperson at Forest commented saying, “As the first long-acting inhaled anticholinergic agent approved in over 8 years for COPD, Tudorza will be an important treatment option.”
Curtis Rosebraugh, MD, Office of Drug Evaluation II, FDA’s Center for Drug Evaluation and Research, Rockville, Maryland, said, “COPD is a serious disease that gets worse over time. The availability of long-term maintenance drugs for COPD provides additional treatment options for the millions of people who suffer with this debilitating disease.”

However, the FDA have also warned that the drug may cause some serious side effects such as paradoxical bronchospasm, new or worsened urinary retention, or new or worsened pressure in the eyes (known as acute narrow-angle glaucoma). The FDA also says the medication is not fit to be used as a rescue therapy to help aid sudden breathing difficulties such as acute bronchospasm.

When Medical Specialists Pharmacy know more about this and other medications that are being approved by the FDA to help with asthma or COPD, we will update our patients immediately. In the meantime, Medical Specialists Pharmacy provides a huge range of medications to help asthma sufferers, all at great prices. If you have already been prescribed an inhaler, have lost your inhaler, or run out and cannot get a prescription immediately, we are able to supply you an inhaler to help your asthma symptoms.   After undergoing a private and confidential online consultation with one of our Doctors, if you are suitable they will then write you a prescription which is passed to our in-house Pharmacists and dispensed to a location of your choice. This is all done discretely and within just 24 hours. We offer both blue (relievers) inhalers such as Ventolin and Salbutamol, and brown (preventers) inhalers such as Qvar Beclomethasone, Qvar Easi-Breathe, and Pulvinal Beclomethasone.

The New York childhood asthma rate is more than US national average

Statistics released by the Center for Disease Control and Prevention (CDC) show that an average of one in eight New York City children have been diagnosed with asthma. This means that the prevalence rate is higher than the US national average for childhood asthma, which is currently about one in ten.

Thomas Matte, assistant commissioner for environmental surveillance and policy, commented on the findings and said, “New York City’s rate on average is higher, but then within the city we know the rate varies dramatically. Our rate is really pulled up by the high rates in poor neighbourhoods.”

Matte gives his opinions on why this is so, and says that households with lower income will probably have more possible asthma triggers such as mould, pest infestations, and the chemicals in cigarette smoke can irritate the lungs. The links between tobacco smoke and lung conditions such as asthma is a topic Medical Specialists Pharmacy previously reported earlier this year, and we advise that asthma suffers must have their reliever inhaler in their possession at all times, especially when there is a risk of being in the presence of somebody who smokes.

He further advises that written instructions for children and parents would be an effective method of managing their asthma.  According to the CDC survey, only one in three children using medication for asthma was actually doing this.

It is calculated that children residing in East Harlem are almost 13 times more likely to require asthma-related hospital treatment in comparison to counterparts living in the Upper East Side. The same report claims that 18% of Hispanic children and 17% of black children have been diagnosed with asthma, and just 5% of white children.

Dr Joshua Needleman, a paediatric pulmonologist at New York-Presbyterian/Weill Cornell Medical Center, says Doctors are already aware of the trends that the report highlights, saying, “You find asthma all over the place, but the kids in the poor areas is where you see the most burden.”

With soaring temperatures currently gripping the US, child and adult asthma sufferers in both poor and wealthy areas will no doubt see their symptoms worsen, and this will apply to those who have hay fever too. Days with high humidity or pollution can especially cause problems for asthma sufferers and this can be dangerous if left untreated. The American College of Allergy, Asthma and Immunology (ACAAI) have said, “Although symptoms may not always be severe, summertime allergies and asthma are serious and, in some cases, deadly.”

At Medical Specialists Pharmacy we offer our patients a huge range of medications to help both asthma and allergy sufferers, all at great prices. If you have already been prescribed an inhaler, have lost your inhaler, or run out and cannot get a prescription immediately, we are able to supply you an inhaler to help your asthma symptoms. After undergoing a private and confidential online consultation with one of our Doctors, if you are suitable they will then write you a prescription which is passed to our in-house Pharmacists and dispensed to a location of your choice. We have both blue (relievers) inhalers such as Ventolin and Salbutamol cheaper than the NHS, and brown (preventers) inhalers such as Qvar Beclomethasone, Qvar Easi-Breathe and Pulvinal Beclomethasone.

An effective treatment for allergic rhinitis (hay fever) is Nasonex nasal spray. Available with or without a prescription, Nasonex is a medication used to help with congestion, sneezing, runny or stuffy nose, and nasal itching due to allergies. It is also prescribed for nasal polyps (small, non-cancerous growths on the lining inside the nose). Prices of this medication are from as little as £9.98 per pack. Our chemist shop has now been expanded to include products such Prevalin allergy nasal spray, Prevalin allergy kids nasal spray and Alomide allergy eye drops, which can all help to ease the symptoms of hay fever.

Poor lung function and vitamin D deficiency could be connected

A study published online in the July 12 edition of American Journal of Respiratory and Critical Care Medicine, has linked a deficiency of vitamin D to a worsening lung function in asthmatic children who are treated by the use of corticosteroid inhalers, such as Qvar Beclometasone or Easi-Breathe.

The study came about after researchers made the observation that the prevalence of both asthma and vitamin D deficiency have increased over the last few years. They then set about the task of uncovering any evidence that may suggest a link between these facts.

The 25-hydroxyvitamin D levels were analysed in the serum of 1,024 children aged between 5 and 12 years old from the Childhood Asthma Management Program. Every child involved in the study was suffering from mild to moderate ‘persistent’ asthma and for the evaluations were randomly given either the nonsteroidal anti-inflammatory agent nedocromil, budesonide (an inhaler corticosteroid), or a placebo.

It was determined by researchers that the children’s level of vitamin D would be judged as <20 ng/mL being deficient, 20 to 30 ng/mL being insufficient and >30 ng/mL would be classed as sufficient.

The results showed that 663 children (about 65%), 260 (about 25%), and 101 (about 10%) of the children in the study had vitamin D levels sufficient, insufficient and deficient, respectively. It was determined that those showing a deficient level of vitamin D were more likely to be older and black, or have a higher body mass index in comparison to those children who had ‘sufficient’ or ‘insufficient’ levels of vitamin D.

Ann Chen Wu, from the Harvard Medical School and one of the leading figures in the study, said, “In conclusion, vitamin D sufficiency in patients treated with inhaled corticosteroids is associated with improved lung function in patients with mild to moderate persistent asthma. Monitoring vitamin D levels and/or supplementing with vitamin D could be considered during inhaled corticosteroid treatment for patients with asthma.”

Dr Wu has acknowledged certain constraints with their study though. For example, the sample size of children with a deficient vitamin D level was particularly small. In addition, Dr Wu admits that the children’s vitamin D levels were analysed just once, this being upon entry into the trial.